Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

99.18 -0.68 (-0.68%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
95 96 Next >
3 Biotech Stocks for Getting Rich in 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist. 
Via InvestorPlace
7 Safe Stocks to Buy as Fed Gears Up for Disinflation
With a hawkish monetary policy the possible outcome of the Federal Reserve impact, these are the safe stocks to buy right now. 
Via InvestorPlace
Merck & Co Unusual Options Activity
Via Benzinga
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
Why Are Dow Stocks Up Today?
The Dow closed in the green today despite some slight weakness in both the S&P 500 and Nasdaq Composite. Why are Dow stocks up today? 
Via InvestorPlace
Peering Into Merck & Co's Recent Short Interest
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
2 Best Biotech Stocks to Buy in July
These are two of the largest pharmaceutical companies on the planet. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
Roivant Surges As Roche Reportedly Considers $7 Billion Drug Takeover
The report sent Roivant Sciences higher Friday, but a deal is far from guaranteed. 
Via Investor's Business Daily
3 Penny Stocks to Catapult You Into the Millionaires’ Club
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up! 
Via InvestorPlace
Bernie Sanders Doesn't Own Individual Stocks But His Mutual Fund Holdings Include Stakes In Companies He's Criticized, Including Tesla
U.S. Sen. Bernie Sanders has made waves over the years for targeting the ultra-wealthy, with some of the billionaires accumulating their wealth through stock investments. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger
Infinity Pharmaceuticals Inc (NASDAQ: INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the  
Via Benzinga
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Read the latest report on NanoViricides here. 
Via Benzinga
Retirement Stocks: Here’s Where to Invest $1,000 Right Now
Retirement strategies focus on long-term potential and dividend management. These retirement stocks meet the mark if you have $1,000 today. 
Via InvestorPlace
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
Read the latest report on NanoViricides here. 
Via Benzinga
The 3 Best Dividend ETFs to Buy for July
If you feel some hesitation toward the economic recovery narrative, these best dividend ETFs should help sleep easier at night. 
Via InvestorPlace
Why Shares of Ventyx Biosciences Rose Monday
The company has several promising autoimmune therapies. 
Via The Motley Fool
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
Both companies are facing significant patent cliffs, but they've been preparing for this moment. 
Via The Motley Fool
Here’s Why Boring Stocks Make Exciting Option Trades
Chasing volatility has its downsides. Sometimes it makes more sense to steer clear of it and instead look for less volatile stocks to trade options on. This also means you'll want to change your... 
Via Talk Markets
Week In Review: CMBG Out-Licenses Two CAR-T Candidates To Janssen For $245 Million Upfront
Via Talk Markets
The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023
Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks. 
Via InvestorPlace
Merck to Hold Second-Quarter 2023 Sales and Earnings Conference Call on Aug. 1
From Merck & Co., Inc.
Via Business Wire
This Sentiment Gauge Just Reached Its Most Optimistic Level Since Pre-Covid Days. Time to Buy Stocks?
Many stocks are trading at reasonable levels after declines last year. 
Via The Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was... 
Via Benzinga
Merck, Ridgeback Withdraw COVID-19 Pill European Application Amid Regulatory Hurdles
Merck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics have reportedly withdrawn their COVID-19 pill application in the European Union (EU). 
Via Benzinga
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
Developmental biomedical device company PetVivo Holdings Inc. (NASDAQ: PETV) makes pet medical devices and therapeutics. What kind of medical devices would 
Via MarketBeat
Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead
After a huge run-up in stocks since January investors have come to realize that most of the gains have come from the so-called “Magnificent Seven” tech stocks. 
Via Talk Markets
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
95 96 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.